Risk factors for myocarditis associated with immune checkpoint inhibitors using real-world clinical data.

被引:0
|
作者
Jain, Prantesh
Bugarin, Jahir Gutierrez
Guha, Avirup
Jain, Chhavi
Shen, Tingke
Stanevich, Ilya
Margevicius, Seunghee P.
Fu, Pingfu
Liu, Fang
Nikore, Vipan
Mangla, Ankit
De Lima, Marcos J. G.
Velcheti, Vamsidhar
Barnholtz-Sloan, Jill
Dowlati, Afshin
机构
[1] Case Western Reserve Univ, Univ Hosp Seidman Canc Ctr, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA
[4] Univ Hosp Seidman Canc Ctr, Cleveland, OH USA
[5] Cleveland Clin, Cleveland, OH 44106 USA
[6] Case Comprehens Canc Ctr, Cleveland, OH USA
[7] NYU Langone, Perlmutter Canc Ctr, New York, NY USA
[8] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH USA
[9] Case Western Reserve Univ, Sch Med, Dept Populat & Quantitat Hlth Sci, Cleveland, OH USA
[10] Case Western Reserve Univ, Case Comprehens Canc Ctr, Univ Hosp Seidman Canc Ctr, Cleveland, OH 44106 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e15100
引用
收藏
页数:2
相关论文
共 50 条
  • [41] A Real-World Comparison of the Safety Profile for Immune Checkpoint Inhibitors in Oncology Patients
    Alwhaibi, Abdulrahman
    Alenazi, Miteb A.
    Alghadeer, Sultan
    Mansy, Wael
    Alsaif, Reem A.
    Abualreesh, Nawaf E.
    Alanazi, Rakan J.
    Alroumi, Abdullah
    Alanazi, Saleh A.
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (02)
  • [42] Real-world use of immune checkpoint inhibitors in advanced or recurrent endometrial cancer
    Huepenbecker, Sarah
    Meyer, Larissa A.
    Craft, Miranda
    Chan, John K.
    Craggs, Christopher
    Lambert, Peter
    Lin, Yvonne G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, : 1719 - 1728
  • [43] Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors
    Flora Pirozzi
    Remo Poto
    Luisa Aran
    Alessandra Cuomo
    Maria Rosaria Galdiero
    Giuseppe Spadaro
    Pasquale Abete
    Domenico Bonaduce
    Gianni Marone
    Carlo Gabriele Tocchetti
    Gilda Varricchi
    Valentina Mercurio
    Current Oncology Reports, 2021, 23
  • [44] Sequential treatment with targeted and immune checkpoint inhibitor therapies in patients with BRAF positive metastatic melanoma: Real-world data.
    Cybulska-Stopa, Bozena
    Czarnecka, Anna Malgorzata
    Ostaszewski, Krzysztof
    Piejko, Karolina
    Zietek, Marcin
    Dziura, Robert
    Rutkowska, Ewa
    Galus, Lukasz
    Ziolkowska, Barbara
    Kempa-Kaminska, Natasza
    Seredynska, Joanna
    Kamycka, Agnieszka
    Bal, Wieslaw
    Surus-Hyla, Anna
    Switaj, Tomasz
    Rogala, Pawel
    Kaminska-Winciorek, Grazyna
    Suwinski, Rafal
    Mackiewicz, Jacek
    Rutkowski, Piotr
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [45] Immune checkpoint inhibitors-associated risk of immune-related hypothyroidism in older patients with advanced melanoma: a real-world analysis of US SEER-Medicare data
    Almutairi, Abdulaali R.
    Erstad, Brian L.
    McBride, Ali
    Slack, Marion
    Abraham, Ivo
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (04) : 489 - 497
  • [46] The efficacy and toxicity of immune checkpoint inhibitors in a real-world older patient population
    Sattar, Joobin
    Kartolo, Adi
    Hopman, Wilma M.
    Lakoff, Joshua Matthew
    Baetz, Tara
    JOURNAL OF GERIATRIC ONCOLOGY, 2019, 10 (03) : 411 - 414
  • [47] Khorana Risk Score for Thrombosis Prediction in Patients with Gynecologic Malignancies Using Immune Checkpoint Inhibitors- a Real-World Validation
    Song, Junmin
    Chang, Yu-Cheng
    Abram, Ana Maria Diaz
    Ahn, Jaeun
    Chi, Kuan-Yu
    Chang, Yu
    Chiang, Cho-Han
    BLOOD, 2024, 144 : 5582 - 5583
  • [48] Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors
    Pirozzi, Flora
    Poto, Remo
    Aran, Luisa
    Cuomo, Alessandra
    Galdiero, Maria Rosaria
    Spadaro, Giuseppe
    Abete, Pasquale
    Bonaduce, Domenico
    Marone, Gianni
    Tocchetti, Carlo Gabriele
    Varricchi, Gilda
    Mercurio, Valentina
    CURRENT ONCOLOGY REPORTS, 2021, 23 (02)
  • [49] Characterization of risk factors and efficacy of medical management of immune-related hepatotoxicity in real-world patients with metastatic melanoma treated with immune checkpoint inhibitors
    Romanski, Nicole A.
    Holmstroem, Ikke B.
    Ellebaek, Eva
    Svane, Inge Marie
    EUROPEAN JOURNAL OF CANCER, 2020, 130 : 211 - 218
  • [50] Real-world incidences and risk factors of immune-related adverse events in patients treated with immune checkpoint inhibitors: A nationwide retrospective cohort study
    Kim, Yong Joon
    Lee, Myeongjee
    Kim, Eun Hwa
    Lee, Seulkee
    Park, Sejung
    Shin, Sang Joon
    Jung, Inkyung
    Lee, Choong-kun
    CANCER LETTERS, 2024, 596